Medicine
Circular 45/2026/TT-BYT amends Vietnam's GMP rules: radiopharmaceuticals, investigational drugs and change control — effective 1 January 2027
The Ministry of Health issued Circular 45/2026/TT-BYT on 1 November 2026, amending Circular 28/2025/TT-BYT on good manufacturing practice for medicines and drug materials. It adds WHO-GMP for investigational drugs and a GMP standard for radiopharmaceuticals made in hospitals, rewrites change control, tightens follow-up of inspection findings and gives foreign plants a way to keep their EU-GMP listing current. It takes effect on 1 January 2027.